Alexander Venus from the group of Marc Fatar, Mannheim, serially investigated APP 23 („Swedish mutation“) transgenic mice by in vivo high-field (9.4T) magnetic resonance imaging (MRI) to visualize amyloid plaques, microbleedings and vasculopathy. This evidence concerns the gene APP and vascular disorder.